Therapeutic Potential of Fisetin, Vitexin and Hesperetin on Chronic Myeloid Leukemia Cells

dc.contributor.author Adan Gökbulut, Aysun
dc.contributor.author Baran, Yusuf
dc.coverage.doi 10.1016/S0145-2126(14)70120-1
dc.date.accessioned 2021-01-24T18:32:26Z
dc.date.available 2021-01-24T18:32:26Z
dc.date.issued 2014
dc.description 5th International Eurasian Hematology Congress en_US
dc.description.abstract In Chronic Myeloid Leukemia (CML) treatment, despite therapeutic efficacy of tyrosine kinase inhibitors, resistance development and side effects cause problems. Fisetin, vitexin and hesperetin are plant-derived flavonoids. In this study, therapeutic potentials of fisetin, vitexin and hesperetin were determined in CML cells. Cytotoxic effects of flavonoids were determined by MTT assay while apoptotic effects were determined by changes in caspase- 3 activity, loss of mitochondrial membrane potential (MMP) and Annexin V/PI double staining. Cytostatic effects of the flavonoids were evaluated by propidium iodide staining using flow cytometry. en_US
dc.identifier.doi 10.1016/S0145-2126(14)70120-1 en_US
dc.identifier.issn 0145-2126
dc.identifier.uri https://doi.org/10.1016/S0145-2126(14)70120-1
dc.identifier.uri https://hdl.handle.net/11147/10123
dc.language.iso en en_US
dc.publisher Elsevier Ltd. en_US
dc.relation.ispartof Leukemia Research en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.title Therapeutic Potential of Fisetin, Vitexin and Hesperetin on Chronic Myeloid Leukemia Cells en_US
dc.type Conference Object en_US
dspace.entity.type Publication
gdc.author.institutional Adan Gökbulut, Aysun
gdc.author.institutional Baran, Yusuf
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.coar.access open access
gdc.coar.type text::conference output
gdc.collaboration.industrial false
gdc.description.department İzmir Institute of Technology. Molecular Biology and Genetics en_US
gdc.description.endpage S48 en_US
gdc.description.publicationcategory Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q3
gdc.description.startpage S48 en_US
gdc.description.volume 38 en_US
gdc.description.wosquality Q3
gdc.identifier.openalex W2077327626
gdc.identifier.wos WOS:000347244200114
gdc.index.type WoS
gdc.oaire.diamondjournal false
gdc.oaire.impulse 0.0
gdc.oaire.influence 2.635068E-9
gdc.oaire.isgreen false
gdc.oaire.popularity 7.742206E-10
gdc.oaire.publicfunded false
gdc.oaire.sciencefields 03 medical and health sciences
gdc.oaire.sciencefields 0302 clinical medicine
gdc.openalex.collaboration National
gdc.openalex.fwci 0.0
gdc.openalex.normalizedpercentile 0.15
gdc.opencitations.count 0
gdc.plumx.mendeley 3
gdc.wos.citedcount 0
relation.isAuthorOfPublication.latestForDiscovery 305b031e-3047-41bb-8d20-94c588bb3a49
relation.isOrgUnitOfPublication.latestForDiscovery 9af2b05f-28ac-4013-8abe-a4dfe192da5e

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Name:
1-s2.0-S0145212614701225-main.pdf
Size:
75.89 KB
Format:
Adobe Portable Document Format
Description:
Conference Object